US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist

3.4400
-0.1700-4.71%

Close May 31 16:00 ET

3.4400
0.00000.00%

Post 18:05 ET

3.24MMarket Cap0.27P/E (TTM)

Avenue Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-61.22%3.19M

-73.42%1.78M

-25.81%161K

76.52%1.57M

349.32%8.24M

78.26%6.71M

-62.91%217K

-20.61%890K

-Cash and cash equivalents

-61.22%3.19M

-73.42%1.78M

-25.81%161K

76.52%1.57M

349.32%8.24M

78.26%6.71M

-62.91%217K

-20.61%890K

Receivables

----

--13K

--26K

--13K

----

--0

-Related party accounts receivable

----

--13K

--26K

--13K

----

--0

Current deferred assets

----

-8.28%310K

----

--338K

----

Other current assets

-41.41%116K

-51.09%67K

-10.00%18K

-40.00%69K

60.98%198K

28.04%137K

-31.03%20K

64.29%115K

Total current assets

-60.81%3.31M

-72.97%1.85M

-12.70%502K

65.77%1.67M

331.85%8.45M

72.85%6.85M

-16.42%575K

-15.62%1.01M

Non current assets

Related parties assets

----

--13K

--26K

--13K

----

--0

Total non current assets

--0

Total assets

-60.81%3.31M

-72.97%1.85M

-12.70%502K

65.77%1.67M

331.85%8.45M

72.85%6.85M

-16.42%575K

-15.62%1.01M

Liabilities

Current liabilities

Payables

77.01%662K

167.33%401K

38.27%560K

65.02%500K

-31.25%374K

-58.56%150K

7.14%405K

40.93%303K

-accounts payable

-6.06%310K

-39.53%78K

-18.68%296K

52.22%446K

-33.06%330K

-57.57%129K

80.20%364K

257.32%293K

-Due to related parties current

700.00%352K

1,438.10%323K

543.90%264K

440.00%54K

-13.73%44K

-63.79%21K

-76.70%41K

-92.48%10K

Current accrued expenses

-94.24%243K

-68.12%198K

684.87%934K

1,344.94%1.29M

1,929.33%4.22M

404.88%621K

-29.17%119K

-24.58%89K

Other current liabilities

-92.78%413K

-77.54%586K

--3.3M

--5.87M

--5.72M

--2.61M

----

Current liabilities

-86.68%1.41M

-66.58%1.2M

718.24%5.02M

1,819.41%7.81M

1,230.49%10.6M

603.14%3.58M

-27.59%614K

-25.87%407K

Non current liabilities

Total non current liabilities

--0

Total liabilities

-86.68%1.41M

-66.58%1.2M

718.24%5.02M

1,819.41%7.81M

1,230.49%10.6M

603.14%3.58M

-27.59%614K

-25.87%407K

Shareholders'equity

Share capital

--0

--3K

--1K

-50.00%1K

--0

0.00%2K

-common stock

--0

--3K

--1K

-50.00%1K

--0

0.00%2K

-Preferred stock

--0

Retained earnings

-8.15%-95.27M

-12.88%-90.93M

-12.87%-91.57M

-14.45%-92.09M

-10.30%-88.09M

-4.61%-80.55M

-6.62%-81.13M

-6.98%-80.46M

Paid-in capital

13.24%98.1M

9.53%92.51M

8.42%87.92M

7.03%86.76M

6.93%86.63M

4.98%84.46M

6.80%81.09M

6.86%81.06M

Total stockholders'equity

295.32%2.84M

-59.49%1.58M

-9,258.97%-3.65M

-992.31%-5.34M

-225.28%-1.45M

13.16%3.91M

75.63%-39K

-6.85%598K

Noncontrolling interests

-33.05%-938K

-45.23%-928K

---872K

---810K

---705K

---639K

----

Total equity

187.99%1.9M

-79.98%654K

-11,494.87%-4.52M

-1,127.76%-6.15M

-286.11%-2.16M

-5.36%3.27M

75.63%-39K

-6.85%598K

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-61.22%3.19M	-73.42%1.78M	-73.42%1.78M	-25.81%161K	76.52%1.57M	349.32%8.24M	78.26%6.71M	78.26%6.71M	-62.91%217K	-20.61%890K
-Cash and cash equivalents	-61.22%3.19M	-73.42%1.78M	-73.42%1.78M	-25.81%161K	76.52%1.57M	349.32%8.24M	78.26%6.71M	78.26%6.71M	-62.91%217K	-20.61%890K
Receivables	----	----	----	--13K	--26K	--13K	----	----	--0	--0
-Related party accounts receivable	----	----	----	--13K	--26K	--13K	----	----	--0	--0
Current deferred assets	----	----	----	-8.28%310K	----	----	----	----	--338K	----
Other current assets	-41.41%116K	-51.09%67K	-51.09%67K	-10.00%18K	-40.00%69K	60.98%198K	28.04%137K	28.04%137K	-31.03%20K	64.29%115K
Total current assets	-60.81%3.31M	-72.97%1.85M	-72.97%1.85M	-12.70%502K	65.77%1.67M	331.85%8.45M	72.85%6.85M	72.85%6.85M	-16.42%575K	-15.62%1.01M
Non current assets
Related parties assets	----	----	----	--13K	--26K	--13K	----	----	--0	--0
Total non current assets	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total assets	-60.81%3.31M	-72.97%1.85M	-72.97%1.85M	-12.70%502K	65.77%1.67M	331.85%8.45M	72.85%6.85M	72.85%6.85M	-16.42%575K	-15.62%1.01M
Liabilities
Current liabilities
Payables	77.01%662K	167.33%401K	167.33%401K	38.27%560K	65.02%500K	-31.25%374K	-58.56%150K	-58.56%150K	7.14%405K	40.93%303K
-accounts payable	-6.06%310K	-39.53%78K	-39.53%78K	-18.68%296K	52.22%446K	-33.06%330K	-57.57%129K	-57.57%129K	80.20%364K	257.32%293K
-Due to related parties current	700.00%352K	1,438.10%323K	1,438.10%323K	543.90%264K	440.00%54K	-13.73%44K	-63.79%21K	-63.79%21K	-76.70%41K	-92.48%10K
Current accrued expenses	-94.24%243K	-68.12%198K	-68.12%198K	684.87%934K	1,344.94%1.29M	1,929.33%4.22M	404.88%621K	404.88%621K	-29.17%119K	-24.58%89K
Other current liabilities	-92.78%413K	-77.54%586K	-77.54%586K	--3.3M	--5.87M	--5.72M	--2.61M	--2.61M	----	----
Current liabilities	-86.68%1.41M	-66.58%1.2M	-66.58%1.2M	718.24%5.02M	1,819.41%7.81M	1,230.49%10.6M	603.14%3.58M	603.14%3.58M	-27.59%614K	-25.87%407K
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	-86.68%1.41M	-66.58%1.2M	-66.58%1.2M	718.24%5.02M	1,819.41%7.81M	1,230.49%10.6M	603.14%3.58M	603.14%3.58M	-27.59%614K	-25.87%407K
Shareholders'equity
Share capital	--0	--3K	--3K	--1K	-50.00%1K	-50.00%1K	--0	--0	--0	0.00%2K
-common stock	--0	--3K	--3K	--1K	-50.00%1K	-50.00%1K	--0	--0	--0	0.00%2K
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-8.15%-95.27M	-12.88%-90.93M	-12.88%-90.93M	-12.87%-91.57M	-14.45%-92.09M	-10.30%-88.09M	-4.61%-80.55M	-4.61%-80.55M	-6.62%-81.13M	-6.98%-80.46M
Paid-in capital	13.24%98.1M	9.53%92.51M	9.53%92.51M	8.42%87.92M	7.03%86.76M	6.93%86.63M	4.98%84.46M	4.98%84.46M	6.80%81.09M	6.86%81.06M
Total stockholders'equity	295.32%2.84M	-59.49%1.58M	-59.49%1.58M	-9,258.97%-3.65M	-992.31%-5.34M	-225.28%-1.45M	13.16%3.91M	13.16%3.91M	75.63%-39K	-6.85%598K
Noncontrolling interests	-33.05%-938K	-45.23%-928K	-45.23%-928K	---872K	---810K	---705K	---639K	---639K	----	----
Total equity	187.99%1.9M	-79.98%654K	-79.98%654K	-11,494.87%-4.52M	-1,127.76%-6.15M	-286.11%-2.16M	-5.36%3.27M	-5.36%3.27M	75.63%-39K	-6.85%598K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall